{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:36Z","timestamp":1787169576025,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Ceftriaxone is a third-generation cephalosporin with broad-spectrum antibacterial activity. Here, we report a case of ceftriaxone-induced cholelithiasis in an adult patient after a short period of administering ceftriaxone. A 57-year-old female was admitted to our hospital for meningitis and treated empirically with ceftriaxone 2 g every 12 hours. Other medications given included vancomycin, ampicillin and acyclovir. Based on culture results and a sensitivity report, ceftriaxone was continued while other medications were discontinued on day three after admission. Her liver function test (LFT) demonstrated an elevation in hepatic transaminases, and alanine and aspartate transaminases peaked on the fifth day (339 and 153 IU\/L, respectively). Computed tomography (CT) and ultrasound (US) confirmed the presence of uncomplicated cholelithiasis. Ceftriaxone was discontinued and switched to cefotaxime 2 g every four hours. Hepatic transaminases started declining after ceftriaxone discontinuation and dropped to normal levels on day nine. After the administration of cefotaxime on the 25\n                      <jats:sup>th<\/jats:sup>\n                      day, repeated US imaging revealed the persistence of biliary sludge. The patient was discharged in a good and stable clinical condition with follow-up planned at the outpatient clinic. When the concentration of ceftriaxone in the gallbladder exceeds the solubility of its calcium salt, precipitation occurs, forming a biliary sludge. Using the Naranjo Probability scale, the score was found to be 4, indicating a possible relationship between ceftriaxone and cholelithiasis. Multiple case reports of ceftriaxone-induced cholelithiasis have been documented previously, most of which focused on children or on the prolonged use of ceftriaxone. However, our case report highlights the development of cholelithiasis in adults after administering ceftriaxone for a short time.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jgid.jgid_11_21","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T05:56:07Z","timestamp":1644904567000},"page":"31-34","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Rapid Onset of Ceftriaxone-Induced Cholelithiasis in an Adult Patient"],"prefix":"10.4103","volume":"14","author":[{"given":"Hani","family":"Abdelaziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"St-Yves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhanad Al","family":"Habash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariu","family":"Calugaroiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Nashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20240828","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","article-title":"Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use","volume":"27","author":"Richards","year":"1984","journal-title":"Drugs"},{"key":"R2-6-20240828","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R3-6-20240828","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1503\/cmaj.111304","article-title":"Acute bacterial meningitis in adults","volume":"184","author":"Moayedi","year":"2012","journal-title":"CMAJ"},{"key":"R5-6-20240828","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000440680","article-title":"Reversible ceftriaxone-induced pseudolithiasis in an adult patient with maintenance hemodialysis","volume":"5","author":"Shima","year":"2015","journal-title":"Case Rep Nephrol Dial"},{"key":"R6-6-20240828","first-page":"161","article-title":"Ceftriaxone-Associated Cholelithiasis in Adult Patients with Bacterial Meningitis","volume":"2","author":"Nakajima","year":"2016","journal-title":"J Infect Dis Ther"},{"key":"R7-6-20240828","first-page":"167","article-title":"High biliary elimination of ceftriaxone in man","volume":"26","author":"Brogard","year":"1988","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"R8-6-20240828","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/0016-5085(90)90486-K","article-title":"Pathogenesis of ceftriaxone- associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility","volume":"99","author":"Shiffman","year":"1990","journal-title":"Gastroenterology"},{"key":"R9-6-20240828","doi-asserted-by":"crossref","first-page":"132452","DOI":"10.1155\/2009\/132452","article-title":"Acute cholecystitis caused by ceftriaxone stones in an adult","volume":"2009","author":"Becker","year":"2009","journal-title":"Case Rep Med"},{"key":"R10-6-20240828","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-115-9-712","article-title":"Ceftriaxone-induced cholelithiasis","volume":"115","author":"Lopez","year":"1991","journal-title":"Ann Intern Med"},{"key":"R11-6-20240828","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.2169\/internalmedicine.8826-17","article-title":"Progressive pseudolithiasis associated with the intravenous administration of ceftriaxone in patients with central nervous system infections","volume":"56","author":"Tsukagoshi","year":"2017","journal-title":"Intern Med"},{"key":"R12-6-20240828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jcu.20228","article-title":"Ceftriaxone-associated biliary pseudolithiasis in children","volume":"34","author":"Biner","year":"2006","journal-title":"J Clin Ultrasound"},{"key":"R13-6-20240828","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4174\/jkss.2011.81.6.423","article-title":"Gallbladder pseudolithiasis caused by ceftriaxone in young adult","volume":"81","author":"Choi","year":"2011","journal-title":"J Korean Surg Soc"},{"key":"R14-6-20240828","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.idcr.2017.06.007","article-title":"A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction","volume":"9","author":"Abe","year":"2017","journal-title":"IDCases"},{"key":"R15-6-20240828","first-page":"31","article-title":"Ceftriaxone induced biliary pseudolithiasis in children: Report of 14 cases","volume":"18","author":"Alehossein","year":"2008","journal-title":"Iran J Pediatr"},{"key":"R16-6-20240828","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1620\/tjem.211.285","article-title":"Pseudolithiasis due to ceftriaxone treatment for meningitis in children: Report of 8 cases","volume":"211","author":"Araz","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"R17-6-20240828","first-page":"643","article-title":"Ceftriaxone- associated nephrolithiasis in children","volume":"23","author":"Fesharakinia","year":"2013","journal-title":"Iran J Pediatr"},{"key":"R18-6-20240828","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1328-0867.2004.01884.x","article-title":"Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: A prospective study","volume":"46","author":"Bor","year":"2004","journal-title":"Pediatr Int"},{"key":"R19-6-20240828","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G","article-title":"Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children","volume":"28","author":"Palanduz","year":"2000","journal-title":"J Clin Ultrasound"},{"key":"R20-6-20240828","first-page":"7502","article-title":"Case report ceftriaxone associated biliary pseudolithiasis in a child: A case report and review of the literature","volume":"11","author":"Du","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"R21-6-20240828","first-page":"202","article-title":"Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: A rare but potentially severe complication","volume":"14","author":"Famularo","year":"1999","journal-title":"Ann Ital Med Int"},{"key":"R22-6-20240828","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2146\/ajhp040452","article-title":"Hepatocellular enzyme elevations in a patient receiving ceftriaxone","volume":"62","author":"Rivkin","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R23-6-20240828","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0960327116658108","article-title":"Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children","volume":"36","author":"Ustyol","year":"2017","journal-title":"Hum Exp Toxicol"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_11_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:54Z","timestamp":1787166594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_11_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jgid.jgid_11_21","relation":{},"ISSN":["0974-777X"],"issn-type":[{"value":"0974-777X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}